Klinisk Biokemi i Norden · 4 2014
| 19
alla händelser behövs mer forskning på området, och
som ofta behövs att klinisk kemi är involverat i kom-
mande studier för att de preanalytiska aspekterna ska
tas om hand på ett adekvat sätt.
Slutsatser
Denna databassökning av plasmaglukosbestäm-
ningar på oselekterade patienter i rutinsjukvård
visar att byte från NaF till citrat-vakuumrör för glu-
kosmätningar ger högre glukosvärden samt betydligt
fler glukossvar i området för nedsatt fasteglukos res-
pektive över beslutsgränsen för diabetes.
Referenser
1. Uchida K, Matuse R, Toyoda E, Okuda S,
Tomita S. A new method of inhibiting gly-
colysis in blood samples. Clin Chim Acta
1988;172:101-8.
2. Chan AY, Swaminathan R, Cockram CS.
Effectiveness of sodium fluoride as a pre-
servative of glucose in blood. Clin Chem
1989;35:315-7.
3. Mikesh LM, Bruns DE. Stabilization of glu-
cose in blood specimens: mechanism of delay
in fluoride inhibition of glycolysis. Clin Chem
2008;54:930-2.
4. Gambino R, Piscitelli J, Ackattupathil TA,
Theriault JL, Andrin RD, Sanfilippo ML,
et al. Acidification of blood is superior to
sodium fluoride alone as an inhibitor of gly-
colysis. Clin Chem 2009;55:1019-21.
5. del Pino IG, Constanso I, Mourin LV, Safont
CB, Vazquez PR. Citric/citrate buffer: an
effective antiglycolytic agent. Clin Chem Lab
Med 2013;51:1943-9.
6. Bruns DE, Knowler WC. Stabilization of glu-
cose in blood samples: why it matters. Clin
Chem 2009;55:850-2.
7. Sacks DB, Arnold M, Bakris GL, Bruns DE,
Horvath AR, Kirkman MS, et al; National
Academy of Clinical Biochemistry; Evidence-
Based Laboratory Medicine Committee of the
American Association for Clinical Chemistry.
Guidelines and recommendations for labo-
ratory analysis in the diagnosis and mana-
gement of diabetes mellitus. Diabetes Care
2011;34:e61-99.
8. Mäkinen K. Experiences of new glycolysis
inhibitors in blood plasma determination.
Kliin Lab 1992;4:85–8.
9. Peake MJ, Bruns DE, Sacks DB, Horvath AR.
It’s time for a better blood collection tube
to improve the reliability of glucose results.
Diabetes Care 2013;36:e2.
10. Gambino R, Bruns DE. Stabilization of glu-
cose in blood samples: out with the old, in with
the new. Clin Chem Lab Med 2013;51:1883-5.
11. Sacks DB. Diagnosis of gestational diabetes
mellitus: it is time for international consen-
sus. Clin Chem 2014;60:141-143.
12. Ridefelt P, Åkerfeldt T, Helmersson-Karlqvist
J. Increased plasma glucose levels after change
of recommendation fromNaF to citrate blood
collection tubes. Clin Biochem 2014;47:625-8.
13. Norman M, Jones I. The shift from fluo-
ride/oxalate to acid citrate/fluoride blood
collection tubes for glucose testing - the
impact upon patient results. Clin Biochem
2014;47:683-5.
14. WHO. Definition and diagnosis of diabetes
mellitus and intermediate hyperglycemia:
report of a WHO/IDF consultation. Geneva:
WHO; 2006.
15. Sacks DB, Arnold M, Bakris GL, Bruns DE,
Horvath AR, Kirkman MS, et al. Guidelines
and recommendations for laboratory analysis
in the diagnosis and management of diabetes
mellitus. Clin Chem 2011;57:e1-e47.
16. Metzger BE, Persson B, Lowe LP, Dyer AR,
Cruickshank JK, Deerochanawong C, et al;
HAPO Study Cooperative Research Group.
Hyperglycemia and adverse pregnancy out-
come study: neonatal glycemia. Pediatrics.
2010;126:e1545-52.
17. Fernandez L, Jee P, Klein MJ, Fischer P, Per-
kins SL, Brooks SP. A comparison of glucose
concentration in paired specimens collected
in serum separator and fluoride/potassium
oxalate blood collection tubes under survey
‘field’ conditions. Clin Biochem 2013;46:285-8.
18. American Diabetes Association. Diagnosis
and classification of diabetes mellitus. Dia-
betes Care 2011;34:S62-9.
